The subject of the order is the delivery of medicinal products Packages 1-14, detailed in Annex 1 to the ToR

Abirateron, described in detail in Annex 1 to the ToR

Epirubicin, described in detail in Annex 1 to the ToR

Etoposide, described in detail in Annex 1 to the ToR

Fludarabine phosphas, described in detail in Annex 1 to the ToR

Ibrutinibum, described in detail in Annex 1 to the ToR

Levofolinic acid sodium, described in detail in Annex 1 to the ToR

Afatinib, described in detail in Annex 1 to the ToR

Atezolizumab, described in detail in Annex 1 to the ToR

Azathioprine, Cyclophosphamide, Letrozole, Methotrexate, described in detail in Annex 1 to the Terms of Reference

Capecitabine, described in detail in Annex 1 to the ToR

Dabrafenibum, described in detail in Annex 1 to the ToR

Darbepoetin alfa, described in detail in Annex 1 to the ToR

Doxorubicin lipos. non-pegylatum, described in detail in Annex 1 to the ToR

Enzalutamide, described in detail in Annex 1 to the ToR